What is REVLIMID lenalidomide. All pharmacies must register with Celgene in order to obtain a supply of Revlimid pharmacists must ensure that they have read and understood the Healthcare Professionals Information Pack for Ireland before dispensing Revlimid to any patient.
Https Www Fda Gov Downloads Drugs Drugsafety Postmarketdrugsafetyinformationforpatientsandproviders Ucm222644 Pdf
REVLIMID lenalidomide is a prescription medicine used to treat adults with multiple myeloma MM in combination with the medicine dexamethasone or as maintenance treatment after autologous hematopoietic stem cell transplantation a type of stem cell transplant that uses your own stem cells.
Revlimid dispensing pharmacies. Guidelines for ordering counseling and dispensing REVLIMID lenalidomide Dispensing pharmacies must be certi ed in the REVLIMID REMS program with Celgene and must be educated in the following dispensing procedures. Is filling prescriptions for REVLIMID for patients with multiple myeloma as maintenance therapy following. As a REVLIMID REMS certified pharmacy you must follow the requirements of the REVLIMID REMS program.
Use of Revlimid lenalidomide is subject to a Risk Evaluation and Mitigation Strategies REMS program that requires provider patient and dispensing pharmacy be enrolled into the program. March 2 2017 The nations largest independent specialty pharmacy is dispensing the newly expanded indication of limited-distribution drug REVLIMID lenalidomide. REVLIMID should not be used to treat.
DPLO is filling prescriptions for REVLIMID lenalidomide for patients with multiple myeloma as maintenance therapy following autologous. Only providers and Pharmacies enrolled into the REMS may prescribe and dispense the drug respectively to individuals who are also in the program. Only prescribers and pharmacies certified with REVLIMID REMS can prescribe and dispense the product to patients who are enrolled and meet all the conditions of the.
Celgene a biotechnology company began marketing Revlimid in 2006 as a treatment for multiple myeloma. Pharmacies must be registered in the RevAid program in order to dispense REVLIMID POMALYST or THALOMID in Canada. Only certified prescribers can prescribe REVLIMID and only certified pharmacies can dispense REVLIMID in the REVLIMID REMS program.
Only accept prescriptions with an authorization number and patient risk. Researchers discovered in 2005 the potential that lenalidomide might have for the treatment of multiple myeloma. This Pharmacy Registration Form must be completed by the Chief Pharmacist or appointed deputy to be able to order and dispense lenalidomide.
A REMS program attempts to manage. To locate your nearest RevAid Registered Pharmacy call the RevAid Program at 1-888-RevAid1 1-888-738-2431. Review incoming REVLIMID prescriptions A.
REVLIMID is only dispensed from REVLIMID REMS program certified pharmacies. Revlimid lenalidomide Pharmacy Registration Form. In order to receive REVLIMID all patients must be enrolled in the REVLIMID REMS program and agree to comply with the requirements of the REVLIMID REMS program.
FLINT Mich March 2 2017 PRNewswire -- Diplomat Pharmacy Inc. To learn more about how to become a certified pharmacy please contact the Celgene Customer Care Center at 1-888-423-5436. McKesson Specialty pharmacists have completed required training and are registered with the RevAssist program which allows them to dispense REVLIMID.
February 23 2021. To reduce fetal exposure to the drug REVLIMID is available only through RevAssist a unique distribution network employing only certified contracted specialty pharmacies. In order to ensure that the actions to minimise the risk of foetal exposure are carried out for all patients dispensing of lenalidomide will only be allowed from pharmacies.
Only prescribers and pharmacies certi ed with the THALOMID REMS program can prescribe and dispense the product to patients who are enrolled and meet all the conditions of the THALOMID REMS program Dispensing pharmacists must be educated on the THALOMID REMS program and on dispensing procedures for THALOMID. Revlimid is related to thalidomide the anti-nausea medicine used to prevent morning sickness in the late 1950s and early 1960s.
